Boxlight Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Boxlight Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||
net income | -3,061,000 | -1,478,000 | -7,089,000 | -17,671,000 | -17,750,000 | -811,000 | -2,924,000 | -3,741,275 | 3,104 | 27 | -4,856 | 6,646,198 | 728,000 | -2,219,000 | -5,169,000 | 7,570,371 | -4,210,904 | -1,425,996 | -1,949,623 | -3,257,957 | -294,496 | -1,162,602 | -4,687,023 | -594,462 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||
amortization of debt premium, discount and issuance cost | 631,000 | 583,000 | 592,000 | |||||||||||||||||||||
benefit from credit losses | 52,000 | -13,000 | 129,000 | |||||||||||||||||||||
paid-in-kind accrual on short-term debt | ||||||||||||||||||||||||
changes in deferred tax assets and liabilities | 0 | -1,000 | -323,000 | -1,254,000 | 1,000 | 1,027,000 | -121,000 | -3,775,346 | 65 | -342 | -377 | |||||||||||||
change in allowance for sales returns and volume rebates | -1,009,000 | -636,000 | -175,000 | 204,000 | -377,232 | |||||||||||||||||||
change in inventory reserve | 32,000 | -8,000 | 86,000 | 1,455,000 | -546,000 | 928,000 | 294,000 | -68,634 | -115 | 672 | 77 | -55,750 | 89,000 | 41,000 | -74,000 | -35,339 | 56,594 | 22,600 | -43,700 | 68,573 | -173,721 | 56,558 | 35,168 | 58,292 |
change in fair value of derivative liabilities | -6,000 | -4,000 | -192,000 | -90,000 | 265,000 | |||||||||||||||||||
stock compensation expense | 441,000 | 243,000 | 549,000 | 1,308,000 | 671,000 | 511,000 | 641,000 | 3,310,335 | 603 | 927 | 1,135 | -3,015,940 | 1,161,000 | 1,182,000 | 677,000 | -864,262 | 345,826 | 248,864 | 271,200 | 242,059 | 574,328 | 159,742 | 161,446 | 417,411 |
depreciation and amortization | 2,075,000 | 2,043,000 | 2,069,000 | 1,966,000 | 2,332,000 | 2,298,000 | 2,263,000 | 9,122,182 | 2,231 | 2,266 | 2,321 | -5,256,825 | 1,697,000 | 1,813,000 | 1,754,000 | -755,571 | 318,355 | 220,374 | 219,450 | 219,942 | 221,634 | 221,262 | 246,147 | 255,308 |
impairment of goodwill | 11,969,000 | |||||||||||||||||||||||
change in right of use assets and lease liabilities | 166,000 | 163,000 | 1,000 | 0 | ||||||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||||
accounts receivable – trade | 5,338,000 | -1,949,000 | 2,947,000 | 11,125,000 | -3,391,000 | -4,578,000 | -2,375,000 | -3,773,760 | -12,401 | -13,043 | -796 | 26,651,573 | -12,098,000 | -13,305,000 | -1,255,000 | 1,442,170 | 273,659 | -1,127,803 | -588,238 | 4,753,430 | -1,062,937 | -5,412,725 | 1,864,532 | 2,985,360 |
inventories | -3,316,000 | 1,344,000 | 4,735,000 | -683,000 | -6,288,000 | 6,505,000 | 13,571,000 | -10,267,278 | -6,732 | 520 | 1,490 | 10,063,002 | -10,121,000 | 1,564,000 | -1,527,000 | 996,597 | -1,503,726 | 30,007 | 477,917 | 31,030 | 4,851 | 296,591 | 962,894 | -362,936 |
prepaid expenses and other current assets | 1,677,000 | -1,600,000 | -1,086,000 | 122,000 | 1,558 | 8,216,530 | -937,000 | -8,082,000 | 800,000 | -226,004 | 1,631,037 | -1,993,419 | 586,392 | -163,527 | -106,447 | -533,163 | 356,544 | 458,125 | ||||||
other assets | -577,000 | 24,000 | 22,000 | -48,000 | -229,000 | -160,668 | -185 | 155,842 | -73,000 | -53,000 | -30,000 | 14,447 | -8,307 | -2,678 | -3,456 | -16,125 | ||||||||
accounts payable and accrued expenses | 2,620,000 | -2,308,000 | -8,103,000 | -3,850,000 | 15,230,000 | -2,357,000 | -13,845,000 | 5,734,408 | 18,623 | 9,879 | -6,910 | -17,846,950 | 6,915,000 | 11,483,000 | -533,000 | 1,325,682 | -1,127,596 | -1,026,274 | 830,364 | 38,367 | -31,237 | 2,207,847 | 641,129 | -985,988 |
other liabilities | 66,000 | -1,758,000 | 3,791,000 | -310,263 | -1,746 | 6 | 3 | 9,991 | -15,000 | 0 | 4,000 | 11,060 | -3,383 | -3,383 | -4,307 | |||||||||
deferred revenues | -149,000 | -12,000 | 105,000 | 612,000 | 391,000 | -542,000 | -171,000 | 3,960,430 | 1,988 | 1,346 | 1,236 | -3,870,682 | 1,340,000 | 1,124,000 | 1,411,000 | 274,406 | 355,462 | -565,345 | -61,676 | 841,815 | -40,473 | -96,370 | -527,506 | -4,839,949 |
net cash from operating activities | 5,220,000 | -5,367,000 | -1,942,000 | 3,339,000 | 8,232,000 | 1,913,000 | -1,903,000 | 1,189,500 | 7,376 | -1,453 | -5,423 | 13,079,670 | -8,512,000 | -3,013,000 | -1,557,000 | 7,013,018 | 2,017,103 | -2,277,662 | -4,567,638 | 564,744 | 12,063 | |||
capex | 132,000 | -17,000 | -394,000 | -1,095,000 | -126,000 | -19,000 | -81,000 | 0 | 0 | -133 | -526 | 138,715 | -91,000 | -2,000 | -46,000 | 0 | 0 | 0 | 0 | 0 | 0 | |||
free cash flows | 5,352,000 | -5,384,000 | -2,336,000 | 2,244,000 | 8,106,000 | 1,894,000 | -1,984,000 | 1,189,500 | 7,376 | -1,586 | -5,949 | 13,218,385 | -8,603,000 | -3,015,000 | -1,603,000 | 7,013,018 | 2,017,103 | -2,277,662 | -4,567,638 | 564,744 | 12,063 | |||
cash flows from investing activities: | ||||||||||||||||||||||||
purchases of furniture and fixtures | 132,000 | -17,000 | -394,000 | -1,095,000 | -126,000 | -19,000 | -81,000 | -133 | -526 | 138,715 | -91,000 | -2,000 | -46,000 | |||||||||||
net cash from investing activities | 132,000 | -17,000 | -394,000 | -1,095,000 | -126,000 | -19,000 | -81,000 | -1,204,940 | -401 | -133 | -526 | 908,992 | -91,000 | -1 | -3,611 | 0 | 10,261 | 0 | ||||||
cash flows from financing activities: | ||||||||||||||||||||||||
proceeds from short-term debt | 2,000,000 | -43,214,775 | 25,919,000 | 9,007,000 | 8,343,000 | -5,656,774 | -3 | 2,850,224 | 2,816,620 | 750,109 | 12,348,843 | 4,869,080 | 4,806,787 | 6,363,628 | ||||||||||
principal payments on short-term debt | -625 | 35,420,088 | -18,070,000 | -8,043,000 | -9,374,000 | 8,944,546 | -2,256,041 | -3,605,393 | -3,091,720 | -3,701,544 | -10,172,581 | -4,092,192 | -5,361,951 | -7,049,179 | ||||||||||
principal payments on long term debt | -2,307,000 | |||||||||||||||||||||||
payments of fixed dividends to series b preferred stockholders | -635,000 | 0 | -317,000 | -317,000 | -317,000 | -318,000 | -317,000 | -1,268,048 | -321 | -314 | -317 | -13,000 | ||||||||||||
proceeds from the exercise of options and warrants | ||||||||||||||||||||||||
net cash from financing activities | -2,963,000 | 1,211,000 | -2,624,000 | -5,024,000 | -3,987,000 | 1,987,000 | -987,000 | -5,130,440 | 3,819 | -7,123,852 | 7,304,000 | 608,000 | -747,000 | -60,664,371 | 49,348,956 | 10,947,343 | 433,650 | -1,745,497 | 2,153,692 | 2,772,443 | 1,279,306 | -685,551 | ||
effect of foreign currency exchange rates | 590,000 | -125,000 | -481,000 | 1,619,000 | -1,293,000 | 433,000 | -346,000 | 1,794,866 | -462 | 408 | 188 | 376,668 | 86,000 | 497,000 | -960,000 | -114,300 | -4,897 | -103,427 | -11,563 | 22,961 | -38,147 | |||
net increase in cash and cash equivalents | 2,979,000 | -1,161,000 | 2,826,000 | -3,351,014 | 7,241,478 | -1,214,000 | -8,424,386 | 3,476,614 | -1,772,234 | 1,816,164 | ||||||||||||||
cash and cash equivalents, beginning of the period | 0 | 0 | 17,253,000 | 0 | 0 | 0 | 14,591,000 | 17,920,062 | 0 | 0 | 17,938 | -13,446,540 | 0 | 0 | 13,460,000 | 0 | 0 | 1,172,994 | 0 | 0 | 901,459 | |||
cash and cash equivalents, end of the period | 2,979,000 | -4,298,000 | 11,812,000 | -1,161,000 | 2,826,000 | 4,314,000 | 11,274,000 | 14,569,048 | 10,332 | 355 | 11,265 | -6,205,062 | -1,214,000 | -2,565,000 | 10,002,000 | 3,476,614 | 5,520,117 | 612,936 | -139,144 | -1,772,234 | 2,717,623 | |||
supplemental cash flow disclosures: | ||||||||||||||||||||||||
cash paid for income taxes | 246,000 | 2,195,000 | 101,000 | 41,000 | 1,758,000 | 840,000 | 52,000 | 1,613,385 | 1,400 | 65 | 150 | -1,456,524 | 427,000 | 852,000 | 179,000 | |||||||||
cash paid for interest | 1,799,000 | 1,847,000 | 1,806,000 | 1,900,000 | 2,340,000 | 2,075,000 | 1,975,000 | 8,334,654 | 3,615 | 2,013 | 1,718 | -2,128,503 | 762,000 | 599,000 | 769,000 | -1,361,531 | 476,801 | 546,733 | 340,313 | 611,909 | 416,064 | 469,068 | 275,676 | 291,558 |
non-cash investing and financing transactions: | ||||||||||||||||||||||||
addition of operating lease liabilities | 408,000 | 125,000 | 52,000 | 496,000 | ||||||||||||||||||||
adjustments to reconcile net income to net cash from (used) in operating activities: | ||||||||||||||||||||||||
principal payments on debt | -708,000 | -670,000 | -11,139,122 | -573 | ||||||||||||||||||||
cash dividends declared to series b preferred stockholders | ||||||||||||||||||||||||
net decrease in cash and cash equivalents | -5,441,000 | -3,317,000 | 355 | -6,673 | -3,458,000 | -560,058 | ||||||||||||||||||
amortization of debt discount and issuance cost | 475,000 | 456,000 | 2,156,355 | 548 | 1,061 | 36 | -1,470,868 | 412,000 | 517,000 | 544,000 | ||||||||||||||
bad debt expense | 206,000 | -71,000 | -116,000 | -10,000 | 265,991 | 1 | -1 | 9 | -66,000 | -167,832 | 74,708 | 102,001 | -8,711 | 160,504 | -26,652 | 63,873 | -116,007 | 22,414 | ||||||
gain on settlement of liabilities | 532,000 | 1,846,000 | -577,344 | 1,718,290 | -53,074 | -1,086,509 | ||||||||||||||||||
change in allowance for sales returns and volume rebate | 90,000 | 315,569 | 240 | 369 | -178 | -540,855 | 215,000 | 177,000 | 150,000 | 91,272 | -22,069 | -70,791 | 1,661 | -163,885 | 65,923 | |||||||||
change in fair value of derivative liability | 224,000 | -2,589,463 | 113 | -1,660 | 10 | -164,013 | -61,000 | 193,640 | 74,363 | -28,663 | -1,372,177 | -263,260 | 2,162,495 | |||||||||||
other short-term liabilities | 304 | -2,232,656 | 1,750,000 | 480,000 | 3,000 | -801,592 | 803,355 | -24,080 | 23,223 | -46,479 | 40,707 | 17,870 | 14,191 | |||||||||||
asset acquisition | ||||||||||||||||||||||||
net proceeds from issuance of common stock and warrants, net of issuance costs | 4,695,300 | |||||||||||||||||||||||
proceeds from issuances of short-term debt | ||||||||||||||||||||||||
proceeds from exercise of options and warrants | ||||||||||||||||||||||||
principal payments on long-term debt | ||||||||||||||||||||||||
proceeds from long term debt | ||||||||||||||||||||||||
proceeds from issuance of common stock | 0 | |||||||||||||||||||||||
shares issued for asset acquisition | 149,850 | |||||||||||||||||||||||
description | ||||||||||||||||||||||||
derivative liabilities - warrant instruments | ||||||||||||||||||||||||
prepaid expenses and other assets | 2,240,000 | 1,108 | ||||||||||||||||||||||
proceeds from long-term debt | ||||||||||||||||||||||||
principal payments on short term debt | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
addition of right of use assets | 17,000 | 26,000 | ||||||||||||||||||||||
change in debt issuance costs | ||||||||||||||||||||||||
(gain) loss on settlement of liabilities | -855,144 | 0 | ||||||||||||||||||||||
shares issued for interest payment on notes payable | -511,383 | 139,000 | 169,000 | 204,000 | -246,240 | 99,555 | 104,814 | 42,370 | ||||||||||||||||
cash paid to settle earnout obligations | 118,881 | |||||||||||||||||||||||
discount on notes payable | -200,000 | |||||||||||||||||||||||
debt issuance costs | 66,676 | -420,000 | 0 | -41,250 | 0 | -4,470 | -165,530 | |||||||||||||||||
other share based payments | ||||||||||||||||||||||||
shares issued to settle accounts payable | -1,624,374 | 0 | -1,000 | 1,627,000 | ||||||||||||||||||||
shares issued for closing fees related to outstanding notes payable – lind global | ||||||||||||||||||||||||
exercise of warrants | -202,650 | 152,000 | ||||||||||||||||||||||
deemed contribution from series b preferred stock | ||||||||||||||||||||||||
non-cash lease expense | ||||||||||||||||||||||||
business acquisitions | 651,396 | 0 | ||||||||||||||||||||||
purchases of property and equipment | ||||||||||||||||||||||||
deemed contribution - series b preferred | 0 | |||||||||||||||||||||||
deferred consideration for acquisition | ||||||||||||||||||||||||
shares issued to convert notes payable and accrued interest | ||||||||||||||||||||||||
settlement of earnout obligations | ||||||||||||||||||||||||
shares issued for acquisition | -402,597 | |||||||||||||||||||||||
declared but unpaid fixed dividends on series b preferred stock | 317,000 | |||||||||||||||||||||||
change in debt issuance cost | ||||||||||||||||||||||||
loss on settlement of liabilities | -2,988,655 | |||||||||||||||||||||||
forgiveness of ppp debt | ||||||||||||||||||||||||
operating lease liability and right of use asset | ||||||||||||||||||||||||
warranty liability | -6 | 87,898 | -1,000 | |||||||||||||||||||||
accounts payable and accrued expenses - related parties | 0 | 16,000 | -170,502 | -80,063 | 270,045 | -283,293 | -573,320 | -42,439 | ||||||||||||||||
net cash used by financing activities | -912 | |||||||||||||||||||||||
shares issued to convert notes payable – lind global | -6,316,005 | 4,033,869 | 1,158,854 | 1,133,515 | ||||||||||||||||||||
bad debt (recovery) expense | 114,425 | 81,000 | ||||||||||||||||||||||
other share-based payments | -7,993 | 0 | 0 | 8,000 | 11,999 | 12,001 | 12,000 | 12,000 | ||||||||||||||||
proceeds from convertible debt | ||||||||||||||||||||||||
proceeds from the paycheck protection plan program loan | ||||||||||||||||||||||||
preferred shares issued as consideration for acquisition of sahara | -29,266,208 | |||||||||||||||||||||||
note payable issued as consideration for acquisition of mystemkits | ||||||||||||||||||||||||
adjustments to reconcile net income to net cash (used) in operating activities: | ||||||||||||||||||||||||
change in deferred tax assets and liabilities | -331,000 | 1,740,000 | -497,000 | |||||||||||||||||||||
cash paid for patents | ||||||||||||||||||||||||
net proceeds from issuance of common stock | 32,025,000 | |||||||||||||||||||||||
proceeds from payment protection plan loan | 0 | |||||||||||||||||||||||
payment on fixed dividends of class b preferred stock | ||||||||||||||||||||||||
shares issued for conversion of notes payable and accrued interest | 3,914,000 | 3,839,000 | 6,033,000 | |||||||||||||||||||||
shares issued for closing fees related to outstanding notes payable | 437,663 | 30,358 | 49,013 | 199,509 | ||||||||||||||||||||
preferred share issued as consideration for acquisition of sahara | ||||||||||||||||||||||||
notes payable issued as consideration for acquisition of mystemkit | 0 | |||||||||||||||||||||||
change in fair value of earn-out payable | -3,240 | 39,075 | -35,523 | |||||||||||||||||||||
settlement of earn out obligations | ||||||||||||||||||||||||
proceeds from the exercise of stock options and warrants | -52,000 | 297,000 | ||||||||||||||||||||||
payments of fixed dividends - series b preferred | ||||||||||||||||||||||||
shares issued for interactive concepts acquisition | ||||||||||||||||||||||||
declared but unpaid fixed dividends - series b preferred | ||||||||||||||||||||||||
deferred consideration for interactive acquisition | -956,000 | 1,493,000 | ||||||||||||||||||||||
7 | ||||||||||||||||||||||||
adjustments to reconcile net income to net cash (used) provided in operating activities: | ||||||||||||||||||||||||
warranty | -80,000 | |||||||||||||||||||||||
acquisition of interactive concepts | -148,000 | |||||||||||||||||||||||
net used in investing activities | -194,000 | |||||||||||||||||||||||
non-cash investment and financing transactions: | ||||||||||||||||||||||||
amortization of debt discount and debt issuance cost | ||||||||||||||||||||||||
warranty reserve | -4,372 | 14,510 | -28,735 | 18,673 | -260,548 | 127,042 | ||||||||||||||||||
accounts payable and accrued expenses – related parties | ||||||||||||||||||||||||
cash receipts from acquisitions | -6,044,180 | 6,049,483 | 0 | 0 | 10,261 | |||||||||||||||||||
cash paid for acquisitions | ||||||||||||||||||||||||
cash paid for furniture and fixtures | -1 | |||||||||||||||||||||||
net cash (used in), provided by investing activities | ||||||||||||||||||||||||
proceeds from subscriptions receivable | ||||||||||||||||||||||||
payment of earn-out payable – related party | ||||||||||||||||||||||||
debt issuance cost | ||||||||||||||||||||||||
proceeds from the payment protection plan | ||||||||||||||||||||||||
effect of currency exchange rates | ||||||||||||||||||||||||
cash and cash equivalents, beginning of the year | ||||||||||||||||||||||||
cash and cash equivalents, end of the year | ||||||||||||||||||||||||
supplemental cash flows disclosures: | ||||||||||||||||||||||||
non-cash investing and financing activities: | ||||||||||||||||||||||||
shares to settle accounts payable | ||||||||||||||||||||||||
shares issued to convert notes payable – harbor gates | ||||||||||||||||||||||||
shares and notes payable issued as consideration for acquisition of modern robotics, inc. net of cash received | 0 | 0 | ||||||||||||||||||||||
shares issued to convert preferred stock | -5 | |||||||||||||||||||||||
amortization of debt discount | 360,411 | 236,467 | 170,830 | 285,111 | 67,287 | 138,609 | 4,839 | 0 | ||||||||||||||||
cash paid related to acquisitions | ||||||||||||||||||||||||
net cash (used) provided by investing activities | -44,953,717 | |||||||||||||||||||||||
proceeds from subscription receivable | 0 | |||||||||||||||||||||||
proceeds from convertible notes payable | 20,000,000 | 0 | 750,000 | 1,250,000 | 0 | 1,800,000 | 2,200,000 | |||||||||||||||||
other | ||||||||||||||||||||||||
shares issued to convert accounts payable | 0 | 702,608 | 566,667 | |||||||||||||||||||||
net cash (used) in operating activities | ||||||||||||||||||||||||
cash paid related to acquisition | ||||||||||||||||||||||||
net cash (used) provided in operating activities | -890,281 | |||||||||||||||||||||||
gain on settlement of derivative liabilities | 0 | |||||||||||||||||||||||
cash receipts from acquisition | ||||||||||||||||||||||||
proceeds from issuance of common stock upon exercise of options | 0 | |||||||||||||||||||||||
payment and change in valuation of earn-out payable – related party | ||||||||||||||||||||||||
shares issued as consideration for acquisition of cohuba | ||||||||||||||||||||||||
shares issued, note payable and earnout out liability as consideration for acquisition of qwizdom | ||||||||||||||||||||||||
shares issued as consideration for acquisition of eos | ||||||||||||||||||||||||
settlement of related party derivative | ||||||||||||||||||||||||
gain on debt conversion | ||||||||||||||||||||||||
gain on settlement of accounts payable | 0 | |||||||||||||||||||||||
deferred charges | ||||||||||||||||||||||||
exercise of options | ||||||||||||||||||||||||
conversion of notes payable | 0 | 0 | 382,525 | |||||||||||||||||||||
shares issued as consideration for the acquisition of cohuborate | ||||||||||||||||||||||||
shares, notes payable and earn-out liability issued as consideration the acquisition of qwizdom | ||||||||||||||||||||||||
shares issued as consideration for the acquisition of eos | ||||||||||||||||||||||||
additional contribution from settlement of related party derivative liability | ||||||||||||||||||||||||
issuance of class a common shares to settle accounts payable | ||||||||||||||||||||||||
shares issue for closing fees related to outstanding notes payable | ||||||||||||||||||||||||
gain on settlements of liabilities | -146,434 | |||||||||||||||||||||||
shares and notes payable issued as consideration for acquisition of modern robotics, inc net of cash received | 559,739 | |||||||||||||||||||||||
loss on disposal of other assets | ||||||||||||||||||||||||
gain on settlement of debt | ||||||||||||||||||||||||
cash paid for acquisition | ||||||||||||||||||||||||
payment made for purchase of intangible assets | ||||||||||||||||||||||||
proceeds from short-term debt – related parties | ||||||||||||||||||||||||
principal payments on short-term debt-related party | ||||||||||||||||||||||||
principal payments on convertible debt – related party | ||||||||||||||||||||||||
distributions to the member of mimio | ||||||||||||||||||||||||
issuance of series a preferred stock for the acquisition of genesis | ||||||||||||||||||||||||
derivative liabilities from issuance of warrants | ||||||||||||||||||||||||
conversion of series b and c preferred stock to common stock upon ipo | ||||||||||||||||||||||||
conversion of convertible note payable – related parties to common stock | ||||||||||||||||||||||||
settlement of short-term debt through issuance of common stock | ||||||||||||||||||||||||
settlement of accounts payable through issuance of common stock | ||||||||||||||||||||||||
settlement of trademark liability at ipo date | ||||||||||||||||||||||||
other share- based payments | ||||||||||||||||||||||||
write-off of equipment | ||||||||||||||||||||||||
accrued interest on long-term debt – related parties | ||||||||||||||||||||||||
proceeds from convertible note payable | ||||||||||||||||||||||||
shares issued, note payable and earn-out liability as consideration for the acquisition of qwizdom | ||||||||||||||||||||||||
additional contribution from settlement of related-party derivative liability | ||||||||||||||||||||||||
issuance of class a common shares to settle accounts payable – related parties | ||||||||||||||||||||||||
issuance of class a common shares to settle long-term convertible notes payable– related parties | ||||||||||||||||||||||||
debt extension fees through increased principal for skyview note | ||||||||||||||||||||||||
cash acquired through the acquisition of boxlight group and mimio | ||||||||||||||||||||||||
proceeds from sale of property and equipment and other assets | ||||||||||||||||||||||||
proceeds from issuance of common stock at ipo | ||||||||||||||||||||||||
decrease in additional paid-in capital due to the acquisitions of mimio and genesis under common control | ||||||||||||||||||||||||
intangibles and goodwill acquired through acquisitions of mimio and boxlight group | ||||||||||||||||||||||||
issuance of note payable and long-term convertible note payable to acquire mimio | ||||||||||||||||||||||||
issuance of series b preferred stock for the acquisition of genesis | ||||||||||||||||||||||||
issuance of series c preferred stock for the acquisition of boxlight group | ||||||||||||||||||||||||
issuance of note payable to settle accounts payable | ||||||||||||||||||||||||
forgiveness of short-term debt – related parties |
We provide you with 20 years of cash flow statements for Boxlight stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Boxlight stock. Explore the full financial landscape of Boxlight stock with our expertly curated income statements.
The information provided in this report about Boxlight stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.